Scientific Sessions 2025  /  Featured Science in EP  /  Discussant
Logo

American Heart Association

  25
  0

Final ID:

Discussant

  • Morin, Daniel  ( Univ of CA San Francisco , San Francisco , California , United States )
    • Author Disclosures:
    Daniel Morin: DO have relevant financial relationships ; Consultant:Zoll:Active (exists now) ; Consultant:Abbott:Active (exists now) ; Speaker:Zoll:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Featured Science in EP

Monday, 11/10/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Efficacy and safety of flecainide compared to amiodarone for atrial fibrillation cardioversion in patients with Coronary Artery Disease and preserved ejection fraction. FLECA-ED trial

Tsioufis Panagiotis-anastasios, Patsilinakos Sotirios, Kafkas Nikos, Tsioufis Konstantinos, Tsiachris Dimitris, Argyriou Nikolaos, Botis Michail, Kordalis Athanasios, Doundoulakis Ioannis, Antoniou Christos-konstantinos, Matthaiopoulos George, Zamanis Ioannis

Strength-Based Exercise is Not Associated with Risk of Ventricular Arrhythmia in Arrhythmogenic Cardiomyopathy – Towards Safer Exercise Options

Chiampas Katia, Calkins Hugh, James Cynthia, Barouch Lili, Muller Steven, Osuji Evans, Jacobsen Alan, Yanek Lisa, Carrick Richard, Gasperetti Alessio, Tichnell Crystal, Murray Brittney

More abstracts from these authors:
Relationships Between Degree of Obesity, Transthoracic Impedance, and Cardioversion Efficacy

Sanchez Alexandra, Morin Daniel, Murphy Barret, Aymond Joshua, Bernard Michael, Hiltbold Aimee, Khatib Sammy, Polin Glenn, Rogers Paul, Castine Michael

You have to be authorized to contact abstract author. Please, Login
Not Available